{"id":"https://openalex.org/W2158735781","doi":"https://doi.org/10.1093/rheumatology/kem070","title":"Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?","display_name":"Combining enzyme specificity and tissue selectivity of cyclooxygenase inhibitors: towards better tolerability?","publication_year":2007,"publication_date":"2007-03-27","ids":{"openalex":"https://openalex.org/W2158735781","doi":"https://doi.org/10.1093/rheumatology/kem070","mag":"2158735781","pmid":"https://pubmed.ncbi.nlm.nih.gov/17459958"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/kem070","doi":"https://doi.org/10.1093/rheumatology/kem070","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/kem070","pdf_url":"https://academic.oup.com/rheumatology/article-pdf/46/6/911/9449765/kem070.pdf","source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/rheumatology/article-pdf/46/6/911/9449765/kem070.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027292872","display_name":"Kay Brune","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K. Brune","raw_affiliation_strings":["FAU Erlangen-Nuremberg, 91054 Erlangen, Germany. Kay.Brune@pharmakologie.med.uni-erlangen.de","FAU Erlangen-Nuremberg, 91054 Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"FAU Erlangen-Nuremberg, 91054 Erlangen, Germany. Kay.Brune@pharmakologie.med.uni-erlangen.de","institution_ids":["https://openalex.org/I181369854"]},{"raw_affiliation_string":"FAU Erlangen-Nuremberg, 91054 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059206584","display_name":"Daniel E. Furst","orcid":"https://orcid.org/0000-0001-7857-2373","observed_orcids":["https://orcid.org/0000-0001-7857-2373","https://orcid.org/0000-0002-4018-7629"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"D. E. Furst","raw_affiliation_strings":["Doerenkamp Professor, FAU Erlangen-Nuremberg, Germany and 1Professor of Rheumatology, University of California at Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Doerenkamp Professor, FAU Erlangen-Nuremberg, Germany and 1Professor of Rheumatology, University of California at Los Angeles, CA, USA","institution_ids":["https://openalex.org/I161318765","https://openalex.org/I181369854"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3486,"currency":"GBP","value_usd":4597},"apc_paid":null,"fwci":0.5666,"has_fulltext":true,"cited_by_count":56,"citation_normalized_percentile":{"value":0.47480916,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"46","issue":"6","first_page":"911","last_page":"919"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclooxygenase-inhibitors","display_name":"cyclooxygenase inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cox-2-selectivity","display_name":"COX-2 selectivity","score":0.7919999957084656},{"id":"https://openalex.org/keywords/cox-1","display_name":"cyclooxygenase-1","score":0.7089999914169312},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8519999980926514},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.6179999709129333},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5109999775886536},{"id":"https://openalex.org/keywords/gastrointestinal-toxicity","display_name":"gastrointestinal toxicity","score":0.8009999990463257},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-distribution","display_name":"drug distribution","score":0.5440000295639038},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.6819999814033508},{"id":"https://openalex.org/keywords/prostaglandins","display_name":"prostaglandins","score":0.8320000171661377},{"id":"https://openalex.org/keywords/anti-inflammatory-efficacy","display_name":"anti-inflammatory efficacy","score":0.5419999957084656},{"id":"https://openalex.org/keywords/pain-relief","display_name":"analgesia","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8681714534759521},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8612908124923706},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.6536869406700134},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.5358245372772217},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.4697836935520172},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42359936237335205},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.292344868183136},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13048243522644043},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.08494341373443604},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006930","descriptor_name":"Hyperalgesia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011453","descriptor_name":"Prostaglandins","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016861","descriptor_name":"Cyclooxygenase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/rheumatology/kem070","doi":"https://doi.org/10.1093/rheumatology/kem070","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/kem070","pdf_url":"https://academic.oup.com/rheumatology/article-pdf/46/6/911/9449765/kem070.pdf","source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},{"id":"pmid:17459958","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17459958","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Journal Article"},{"id":"mag:2322932094","doi":null,"is_oa":false,"landing_page_url":"https://www.cabdirect.org/cabdirect/abstract/20103192882","pdf_url":null,"source":{"id":"https://openalex.org/S4306518442","display_name":"Le Nouveau Praticien V\u00e9t\u00e9rinaire Canine - F\u00e9line","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Le Nouveau Praticien V\u00e9t\u00e9rinaire Canine - F\u00e9line","raw_type":null}],"best_oa_location":{"id":"doi:10.1093/rheumatology/kem070","doi":"https://doi.org/10.1093/rheumatology/kem070","is_oa":true,"landing_page_url":"https://doi.org/10.1093/rheumatology/kem070","pdf_url":"https://academic.oup.com/rheumatology/article-pdf/46/6/911/9449765/kem070.pdf","source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2158735781.pdf","grobid_xml":"https://content.openalex.org/works/W2158735781.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W181315115","https://openalex.org/W1130176446","https://openalex.org/W1276805569","https://openalex.org/W1612226764","https://openalex.org/W1717393871","https://openalex.org/W1870315080","https://openalex.org/W1909524217","https://openalex.org/W1961189376","https://openalex.org/W1964056979","https://openalex.org/W1967618023","https://openalex.org/W1976526696","https://openalex.org/W1978504750","https://openalex.org/W1979319200","https://openalex.org/W1980983414","https://openalex.org/W1985247069","https://openalex.org/W2001162433","https://openalex.org/W2008570013","https://openalex.org/W2013166307","https://openalex.org/W2020846765","https://openalex.org/W2026547968","https://openalex.org/W2040040765","https://openalex.org/W2040424319","https://openalex.org/W2041349928","https://openalex.org/W2042302038","https://openalex.org/W2052483630","https://openalex.org/W2054195861","https://openalex.org/W2054883739","https://openalex.org/W2057685090","https://openalex.org/W2063230422","https://openalex.org/W2064784115","https://openalex.org/W2066489298","https://openalex.org/W2070999329","https://openalex.org/W2083651943","https://openalex.org/W2089288753","https://openalex.org/W2095127972","https://openalex.org/W2096874183","https://openalex.org/W2100631748","https://openalex.org/W2102368544","https://openalex.org/W2104379105","https://openalex.org/W2106393968","https://openalex.org/W2107011563","https://openalex.org/W2110107835","https://openalex.org/W2125376440","https://openalex.org/W2125471714","https://openalex.org/W2134634779","https://openalex.org/W2134907255","https://openalex.org/W2138224872","https://openalex.org/W2141363952","https://openalex.org/W2151534353","https://openalex.org/W2161097107","https://openalex.org/W2162582390","https://openalex.org/W2163306078","https://openalex.org/W2330496155","https://openalex.org/W2396727318","https://openalex.org/W2404003754","https://openalex.org/W2405309425","https://openalex.org/W2432180685","https://openalex.org/W4230571057"],"related_works":["https://openalex.org/W2089056350","https://openalex.org/W2084447650","https://openalex.org/W1567838639","https://openalex.org/W2186926437","https://openalex.org/W2063230422","https://openalex.org/W2020043659","https://openalex.org/W130440447","https://openalex.org/W2083748640","https://openalex.org/W1495534664","https://openalex.org/W2093565689"],"abstract_inverted_index":{"Inhibitors":[0],"of":[1,27,44,71,79,179,220,253],"cyclooxygenases":[2],"(COXs)":[3],"are":[4,22,41,138,144],"the":[5,36,62,68,77,92,113,159,177,197,211,217,221,224,259],"most":[6],"widely":[7],"used":[8],"drugs.":[9],"They":[10,106],"reduce":[11,61,176],"discomfort":[12],"and":[13,17,29,32,46,51,65,116,132,151,184,199,213,223,245],"fever,":[14,47],"inhibit":[15,214],"peri-operative":[16],"inflammatory":[18],"pain.":[19],"These":[20,87,174],"effects":[21,137,256],"largely":[23],"mediated":[24],"by":[25,240],"inhibition":[26],"cyclooxygenase-1":[28],"-2":[30],"(COX-1":[31],"COX-2)-enzymes":[33],"found":[34],"throughout":[35,91,210],"body":[37,212],"producing":[38],"prostaglandins,":[39],"which":[40,143],"important":[42],"mediators":[43],"pain":[45],"but":[48],"also":[49,108,153],"adaptive":[50],"protective":[52],"reactions":[53,183],"in":[54,97,112,216,236],"many":[55],"organs.":[56],"A":[57,162],"first":[58],"step":[59,164,233],"to":[60,66,196,228,248],"overall":[63],"toxicity":[64],"increase":[67],"anti-inflammatory":[69,84],"activity":[70],"these":[72,136],"drugs":[73,85],"was":[74,168],"achieved":[75,169],"with":[76,141,170],"development":[78],"acidic":[80],"'non-selective'":[81],"(traditional)":[82],"non-steroidal":[83],"(tNSAIDs).":[86],"agents":[88,175],"distribute":[89,208],"unequally":[90],"body,":[93],"reaching":[94],"effective":[95,110],"concentrations":[96,111],"inflamed":[98],"tissue":[99,246],"(effect":[100],"compartment)":[101],"for":[102],"prolonged":[103],"time":[104],"periods.":[105],"can":[107,122],"reach":[109],"bloodstream,":[114],"kidney":[115,130,225],"gastrointestinal":[117],"(GI)":[118],"mucosa,":[119],"where":[120],"they":[121,191,207],"cause":[123],"unwanted":[124,254],"effects,":[125],"such":[126],"as":[127],"GI":[128,180],"toxicity,":[129,181],"dysfunction":[131],"cardiovascular":[133,198],"impairment.":[134],"All":[135],"particularly":[139],"prominent":[140],"compounds":[142],"eliminated":[145],"slowly":[146],"[half-life":[147],"(T((1/2)))":[148],">12":[149],"h]":[150],"thus":[152],"block":[154],"prostaglandin":[155],"production":[156],"permanently":[157,226],"outside":[158],"effect":[160],"compartment.":[161],"second":[163],"towards":[165,234],"improving":[166],"safety":[167,237],"selective":[171],"COX-2":[172,215],"inhibitors.":[173],"incidence":[178],"pseudo-asthmatic":[182],"blood":[185],"loss":[186],"following":[187],"surgical":[188],"interventions.":[189],"However,":[190],"may":[192],"be":[193],"more":[194],"toxic":[195],"renal":[200],"systems":[201],"than":[202],"some":[203],"tNSAIDs,":[204],"possibly":[205],"because":[206],"homogeneously":[209],"endothelial":[218],"layer":[219],"vessels":[222],"due":[227],"their":[229],"slow":[230],"elimination.":[231],"Another":[232],"improvement":[235],"appears":[238],"possible":[239],"combining":[241],"both":[242],"enzyme":[243],"specificity":[244],"selectivity,":[247],"achieve":[249],"a":[250],"further":[251],"reduction":[252],"drug":[255],"while":[257],"maintaining":[258],"anti-inflammatory/analgesic":[260],"efficacy.":[261]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}